The challenge of further reducing cardiac mortality in the thrombolytic era.
Nicod
P
P
Zimmermann
M
M
Scherrer
U
U
D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D012307:Risk Factors; D016019:Survival Analysis
D005343:Fibrinolytic Agents